GlassScriptPhysician profile
Sharon S Margulies
NPI 1144268434
$550.61
in general payments reported to CMS, 2019-2025
12 companies · $27.61 in 2025
The $27.61 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $57.61 · 2021: $104 · 2022: $46.66 · 2023: $30.28 · 2024: $79.23 · 2025: $27.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $110.83 | 2019-2022 | |
| Pfizer INC. | $67.12 | 2019-2021 | |
| Evofem Biosciences, INC. | $65.54 | 2021 | |
| Astellas Pharma US INC | $62.27 | 2024-2025 | Veozah |
| Lupin INC. | $59.36 | 2019-2020 | |
| Allergan, INC. | $39.70 | 2019 | |
| Abbvie INC. | $34.62 | 2019 | |
| Medtronic, INC. | $30.28 | 2023 | Interstim |
| Sage Therapeutics, LLC | $26.47 | 2024 | |
| Organon LLC | $21.96 | 2022 | |
| Coopersurgical, INC. | $18.10 | 2024 | Paragard T 380a |
| Minerva Surgical, INC | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Margulies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.